Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van der Walt

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Curationis|December 1, 1990
[Good and poor research]T van der Walt
The Onderstepoort Journal of Veterinary Research|June 1, 1980
A haemagglutination and haemagglutination inhibition test for bluetongue virusN T van der Walt
The Onderstepoort Journal of Veterinary Research|June 1, 1979
Factors affecting the bluetongue virus neutralizing antibody response and the reaction between virus and antibodyN T van der Walt
IEEE Transactions on Neural Networks|January 1, 1995
Process modeling with the regression networkT van der Walt, E Barnard, J van Deventer
Progress in Clinical and Biological Research|January 1, 1985
Immune response against the purified serotype specific antigen of bluetongue virus and initial attempts to clone the gene that codes for the synthesis of this proteinH Huismans, N T van der Walt, B J Erasmus
European Journal of Cancer. Part B, Oral Oncology|October 1, 1993
Salivary immunoglobulin related proteins in 24 patients with multiple myelomaE Raubenheimer, W van Heerden, J Dauth, et al.
Virology|March 1, 1987
Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheepH Huismans, N T van der Walt, M Cloete, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Linoleic acid levels in cutaneous tumors with different growth patterns as an additional sensitive diagnostic featureL Louw, A M Engelbrecht, F Cloete, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2012
A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivativeCristina Müller, Konstantin Zhernosekov, Ulli Köster, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Curationis|December 1, 1990
[Good and poor research]T van der Walt
The Onderstepoort Journal of Veterinary Research|June 1, 1980
A haemagglutination and haemagglutination inhibition test for bluetongue virusN T van der Walt
The Onderstepoort Journal of Veterinary Research|June 1, 1979
Factors affecting the bluetongue virus neutralizing antibody response and the reaction between virus and antibodyN T van der Walt
IEEE Transactions on Neural Networks|January 1, 1995
Process modeling with the regression networkT van der Walt, E Barnard, J van Deventer
Progress in Clinical and Biological Research|January 1, 1985
Immune response against the purified serotype specific antigen of bluetongue virus and initial attempts to clone the gene that codes for the synthesis of this proteinH Huismans, N T van der Walt, B J Erasmus
European Journal of Cancer. Part B, Oral Oncology|October 1, 1993
Salivary immunoglobulin related proteins in 24 patients with multiple myelomaE Raubenheimer, W van Heerden, J Dauth, et al.
Virology|March 1, 1987
Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheepH Huismans, N T van der Walt, M Cloete, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Linoleic acid levels in cutaneous tumors with different growth patterns as an additional sensitive diagnostic featureL Louw, A M Engelbrecht, F Cloete, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2012
A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivativeCristina Müller, Konstantin Zhernosekov, Ulli Köster, et al.
Pageof 1